A recent market study published by Fact.MR states that the galacto oligosaccharide market is likely to grow at a booming 9.3% value CAGR during the forecast period 2018-2028. The study predicts that galacto oligosaccharide revenues will double over the next decade, despite challenges posed by stringent regulations on the use of prebiotics as a functional ingredient and other labeling regulations. The Fact.MR study offers analysis on wide-ranging macro and microeconomic factors influencing the galacto oligosaccharide market.
Galacto oligosaccharide (GOS) is gaining significant uptake in the infant nutrition industry on account of positive perception about its therapeutic effect on gut health and immunity development. Increase in the number of lactose intolerant population continues to be a challenge for policy makers. According to a journal published by the National Center for Biotechnology Information (NCBI) in 2017, around 70% of the world’s population suffer from lactose intolerance due to a genetically programmed gradual decline in lactase expression, known as lactase non-persistence (LNP). The availability of plant-based galacto oligosaccharide has proven to be highly beneficial with regards to meeting the nutritional requirements of the lactose intolerant population. The infant nutrition industry will be looking to capitalize on the opportunity presented by commercialization of plant-based galacto oligosaccharides.
Request Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1707
The broader trends impacting the dietary fibers industry have a profound impact on the prospects of galacto oligosaccharide industry. The recent FDA approval on eight dietary fibers, including galacto oligosaccharide is likely to create a scramble for launching new products.. With this approval, key manufacturers are broadening the horizon of galacto oligosaccharide that could help them seize premium opportunities. Key dairy cooperative companies are using galacto oligosaccharide in beverages owing to its stability, as addition of fibers in beverages still remains a challenge due to their insolubility or grittiness.
The demand for galacto oligosaccharide in nutraceuticals is likely to grow at a steady clip during the assessment period. The stability of galacto oligosaccharide in high temperatures and low pH applications makes it an ideal fit for neutraceutical products. Prominent nutritional supplement products such as Bimuno, which is meant for the well-being of gut health, contains galacto oligosaccharide in its ingredient profile., The composition for galacto oligosaccharide in neutraceutical products might vary according to the chain length and linkage type between the monomer units.
Strict regulations and legislations related to the use of prebiotic ingredient can be a key factor hampering use of galacto oligosaccharide. Any product before receiving the recognition as a prebiotic or probiotic, is consistently subjected to multiple validations and has to persistently prove its efficacy. It cannot be directly labeled as such, until and unless it is approved by the concerned agencies. Being operating in the food ingredient industry, galacto oligosaccharide is exposed to similar kind of legislations by various food regulation authorities such as FDA and food and agriculture organization. This might create hurdles for prosperity of galacto oligosaccharide, thereby impacting the galacto oligosaccharide market landscape.
Liquid Galacto Oligosaccharide Continues to Outsell Powdered Variants; Latter Growing at Higher Rate
Galacto oligosaccharide products are available in both liquid and powder form. The liquid galacto oligosaccharide is foreseen to sustain its supremacy and is anticipated to hold around 59% of the global market share by 2028. The liquid galacto oligosaccharide finds extensive applications across food products such as beverages, fermented milk, & so on. The powder galacto oligosaccharide is expected to grow on a relentless rate with its use as an additive in infant formula and nutraceuticals
The competitive dynamics included in the report on galacto oligosaccharide market offers a deep dive into the competitive intensity of the market. The galacto oligosaccharide market is characterized by the presence of a limited number of players holding substantial shares. Some of the key players operating in the galacto oligosaccharide market, who have been profiled in the report include Yakult Pharmaceuticals Pvt Ltd, Royal Friesland Campina N.V, Nissin Sugar Co., Ltd., Ingredion Incorporated, Kerry Inc., Quantum Hi-Tech (China) Biological Co., Ltd., Dairy Crest., Baolingbao Biology Co., Ltd., Samyang Corporation, New Francisco Biotech Company.
The Yakult Pharmaceutical industry Co., a leading player in the galacto oligosaccharide market, is vying to expand its services in various countries such as China, Vietnam, USA, Brazil, India, Mexico, Myanmar and Middle East. The company had launched Yakult Light, a low-calorie variant of fermented milk, to offer product differentiation as per diverse customer needs.
Royal Friesland Campina N.V., another prominent player in the galacto oligosaccharide market, established a new production facility for Vivinal GOS in Borculo, Netherlands for responding to surging demand of high quality ingredient in infant nutrition. Also, the company collaborated with Glycosyn to introduce next-generation infant nutrition products.Nissin Sugar Co., Ltd., an eminent player in the galacto oligosaccharide market, is concentrating on producing sugar substitutes which can be used by manufacturers to cater to the health-savvy demographic.
Manufacturers operating in the galacto oligosaccharide market are extensively focusing on R&D activities to enhance their product portfolio and to keep up with the emerging trends of galacto oligosaccharide market.
Enquire about this Report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1707